Bin Huang is an executive leader with over 30 years of experience in life sciences. Ms. Huang's career began with Allelix Crop Technologies, where she spent six years as a plant research scientist. For a number of years Ms. Huang was the president and CEO of Cytovax Biotechnologies, a Canadian biotechnology company. Following that, she led WEX Pharmaceuticals, a subsidiary of publicly listed CK Life Sciences International (Holdings) Inc., as president and CEO. Ms. Huang has a PhD in Plant Cell Biology from the University of East Anglia, UK and an MBA from the University of Toronto.